Media Centre

Find out more about the latest news at Virtus Health, including medical breakthroughs in fertility treatment, growth within our network, and research papers.

Contact Us for comment on recent developments in the industry or interview requests.

Solid first half results show continued growth in revenue and earnings

Solid first half results show continued growth in revenue and earnings

Read more »

 

Half Year financial results – investor conference call details

Virtus Health Limited (ASX: VRT) will release its financial results for the half year ended 31 December 2013 on Wednesday 26th February, 2014.
 
Investors are invited to join a conference call hosted by Sue Channon, Group CEO and Glenn Powers, CFO and Company Secretary of Virtus from 10.00am to 10.45am (AEDT) on Wednesday, 26th February 2014.
 
Download conference call dial in details »

Virtus Health excels at FSA 2013

Virtus Health has reinforced its commitment to investing in scientific leadership and world-class technology for its patients with its outstanding involvement at this year’s Fertility Society of Australia (FSA) conference, hosted in Sydney from 1-4 September.

World Breakthrough - First Pregnancy From Ovarian Tissue Grafted in the Anterior Abdominal Wall

Virtus Health's world leading fertility preservation team, led by Associate Professor Kate Stern, Head of Fertility Preservation at Melbourne IVF and the Royal Women’s Hospital announced the world’s first pregnancy from ovarian tissue grafted in the anterior abdominal wall of a Victorian woman.

The Melbourne woman, Vali, sought the tissue preservation treatment to help save her fertility after the loss of ovarian function through cancer treatment.

Prior to surgery to remove her second ovary at the age of 23, she requested the ovarian tissue be frozen.

A/Prof John McBain honoured with an Order of Australia

Virtus Health congratulates A/Prof John McBain for the acknowledgement he received for his work in Reproductive Medicine by being honoured with an Order of Australia (AO) over the Queen’s Birthday long weekend.

It gave us great pleasure to see such high public recognition for the pioneering work John has achieved throughout his career. We are incredibly proud of his founding role in the formation of Melbourne IVF and the ongoing passion he has for patients and medical science.

City West Specialist Day Hospital reopens in Western Sydney

Today Virtus Health is pleased to announce the reopening of City West Specialist Day Hospital (formerly City West Day Surgery) in Westmead, Sydney.
 
Six specialist private hospitals are now being operated under the Virtus Health umbrella in Sydney, Melbourne, Brisbane and Mackay.
 

Virtus Health’s Achievements at the FSA Conference

Virtus Health operates world-class technology and scientific processes in the field of Assisted Reproductive Technologies and our technology and scientific leadership is verified by the large number of  peer reviewed  and published research papers and presentations at conferences both in Australia and overseas. Our clinicians and scientists travel the world presenting research, new techniques and patient outcome data.

City East Specialist Day Hospital becomes the newest addition to the Virtus Health Portfolio

Virtus Health is pleased to announce the acquisition of Maroubra Day Surgery in Sydney.

Collaboration with the shareholders of the Maroubra Day Surgery initially commenced in 2004, when IVFAustralia relocated its IVF clinic from the Royal Women’s Hospital in Randwick to the same building as the Maroubra Day Surgery and entered into a joint venture partnership with the Maroubra Day Surgery shareholders. The partnership was highly successful with the doctors and staff working to enhance all aspects of the day surgery and patient experience.

IVF Pregnancy Rates Significantly Increased Through Full Chromosomal Testing

Dr Leeanda Wilton, Scientific Director Preimplantation Genetics at Virtus Health, presented at the world’s largest annual specialised reproductive medicine meeting, ESHRE, her award winning research1 into 24Sure Array CGH (comparative genomic hybridization), the technology that has been shown in an American study2 to increase IVF pregnancy rates by up to 65%.

Investing in the Health of Mackay

Mackay Specialist Day Hospital (formerly Mackay Day Surgery) was acquired by Virtus Health in February 2012. It is now managed by our Queensland Fertility Group team and a significant investment into its future has already begun.

The purchase of additional equipment and instrumentation is allowing operating sessions to be extended in order to meet the growing demands of the Mackay community.

Career Opportunities

Interested in joining our team? Read about our current opportunities for fertility specialists.
Find out more...

© Virtus Group 2013